LLY

762.79

+0.4%↑

JNJ

174.31

-1.4%↓

ABBV

221.87

+0.84%↑

UNH

334.97

-1.8%↓

AZN

77.08

-0.7%↓

LLY

762.79

+0.4%↑

JNJ

174.31

-1.4%↓

ABBV

221.87

+0.84%↑

UNH

334.97

-1.8%↓

AZN

77.08

-0.7%↓

LLY

762.79

+0.4%↑

JNJ

174.31

-1.4%↓

ABBV

221.87

+0.84%↑

UNH

334.97

-1.8%↓

AZN

77.08

-0.7%↓

LLY

762.79

+0.4%↑

JNJ

174.31

-1.4%↓

ABBV

221.87

+0.84%↑

UNH

334.97

-1.8%↓

AZN

77.08

-0.7%↓

LLY

762.79

+0.4%↑

JNJ

174.31

-1.4%↓

ABBV

221.87

+0.84%↑

UNH

334.97

-1.8%↓

AZN

77.08

-0.7%↓

Search

REVOLUTION Medicines Inc

Closed

SectorHealthcare

45.22 2.73

Overview

Share price change

24h

Current

Min

43.98

Max

45.33

Key metrics

By Trading Economics

Income

-34M

-248M

EPS

-1.13

Profit margin

-74.379

Employees

700

EBITDA

-24M

-261M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+59.37% upside

Market Stats

By TradingEconomics

Market Cap

1.8B

8.7B

Previous open

42.49

Previous close

45.22

News Sentiment

By Acuity

17%

83%

103 / 371 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

REVOLUTION Medicines Inc Chart

Past performance is not a reliable indicator of future results.

Related News

18 Sept 2025, 23:56 UTC

Hot Stocks

Stocks to Watch: FedEx, 22nd Century, Scholastic

18 Sept 2025, 22:01 UTC

Major Market Movers

22nd Century Group Shares Gain on Debt Repayment, New Capital

18 Sept 2025, 20:51 UTC

Acquisitions, Mergers, Takeovers

UPS Terminates Plan to Buy Estafeta

18 Sept 2025, 20:31 UTC

Earnings

FedEx 1Q Profit, Sales Rise on Improvement in U.S. Shipping -- Update

18 Sept 2025, 20:26 UTC

Earnings

FedEx 1Q Profit, Sales Rise on Improvement in U.S. Shipping

18 Sept 2025, 23:43 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

18 Sept 2025, 23:43 UTC

Market Talk

Nikkei May Rise on U.S. Stock Gains, Weaker Yen -- Market Talk

18 Sept 2025, 23:43 UTC

Market Talk

Global Equities Roundup: Market Talk

18 Sept 2025, 23:40 UTC

Market Talk

Gold Edges Lower Amid Cautious Mood -- Market Talk

18 Sept 2025, 23:31 UTC

Market Talk

FedEx Says U.S. Demand Is Resilient -- Market Talk

18 Sept 2025, 22:03 UTC

Earnings

FedEx Expects Trade Environment to Create $1B Headwind in 2026, CFO Says

18 Sept 2025, 22:01 UTC

Earnings

FedEx CFO: Asia-to-U.S. Declines Drove $150M International Export Headwind

18 Sept 2025, 21:56 UTC

Earnings

Lennar Missed Revenue Estimates. The Stock Is Down. -- Barrons.com

18 Sept 2025, 21:54 UTC

Earnings

FedEx Focused on Demand From Southeast Asia, Europe Amid China Shipping Slowdown, Customer Chief Says

18 Sept 2025, 21:48 UTC

Earnings

FedEx International Export Volumes Declined, Especially on China-to-U.S. Lane, Exec Says

18 Sept 2025, 21:47 UTC

Earnings

FedEx Had 5% Increase in U.S. Domestic Average Daily Package Volume in 1Q, Customer Chief Says

18 Sept 2025, 21:17 UTC

Earnings

FedEx Profit, Sales Rise on Improvement in U.S. Shipping -- 2nd Update

18 Sept 2025, 21:07 UTC

Earnings

FedEx Earnings Were a Relief. The Stock Is Up. -- Barrons.com

18 Sept 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

18 Sept 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

18 Sept 2025, 20:50 UTC

Market Talk
Earnings

Financial Services Roundup: Market Talk

18 Sept 2025, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

18 Sept 2025, 20:22 UTC

Acquisitions, Mergers, Takeovers

UPS Cites Inability of All Closing Conditions to Be Satisfied

18 Sept 2025, 20:22 UTC

Acquisitions, Mergers, Takeovers

United Parcel Service Terminates Plan to Buy Estafeta

18 Sept 2025, 20:20 UTC

Acquisitions, Mergers, Takeovers

Here's How Much the U.S. Has Made on Its Intel Stock Purchase -- Barrons.com

18 Sept 2025, 20:18 UTC

Earnings

Nucor Stock Falls After Earnings. Why Its Guidance Was Far Off Rival Steel Dynamics. -- Barrons.com

18 Sept 2025, 20:18 UTC

Earnings

Bullish Crushes Earnings. The Crypto Stock Pops. -- Barrons.com

18 Sept 2025, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

18 Sept 2025, 20:07 UTC

Earnings

FedEx Earnings Were a Relief. The Stock Is Up. -- Barrons.com

18 Sept 2025, 20:03 UTC

Earnings

FedEx 1Q FedEx Freight Segment Revenue $2.26B >FDX

Peer Comparison

Price change

REVOLUTION Medicines Inc Forecast

Price Target

By TipRanks

59.37% upside

12 Months Forecast

Average 71.24 USD  59.37%

High 80 USD

Low 37.91 USD

Based on 15 Wall Street analysts offering 12 month price targets forREVOLUTION Medicines Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

15 ratings

15

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

40.67 / 41.96Support & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

103 / 371 Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About REVOLUTION Medicines Inc

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies. Its RAS(ON) inhibitors include RMC-6236 (multi), RMC-6291 (G12C), and RMC-9805 (G12D), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C), as well as programs focused on G12R and other targets. The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; and RMC-5552, which is in phase 1 clinical trial. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
help-icon Live chat